Peters M - Search Results

1

Perinatal management of a preterm neonate affected by hyperprostaglandin E2 syndrome (HPS).

Kömhoff M, Tekesin I, Peters M, Leonhard A, Seyberth HW. Kömhoff M, et al. Among authors: peters m. Acta Paediatr. 2005 Nov;94(11):1690-3. doi: 10.1080/08035250510043897. Acta Paediatr. 2005. PMID: 16303714

2

Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide.

Nüsing RM, Reinalter SC, Peters M, Kömhoff M, Seyberth HW. Nüsing RM, et al. Among authors: peters m. Clin Pharmacol Ther. 2001 Oct;70(4):384-90. Clin Pharmacol Ther. 2001. PMID: 11673754 Clinical Trial.

3

Salt handling in the distal nephron: lessons learned from inherited human disorders.

Jeck N, Schlingmann KP, Reinalter SC, Kömhoff M, Peters M, Waldegger S, Seyberth HW. Jeck N, et al. Among authors: peters m. Am J Physiol Regul Integr Comp Physiol. 2005 Apr;288(4):R782-95. doi: 10.1152/ajpregu.00600.2004. Am J Physiol Regul Integr Comp Physiol. 2005. PMID: 15793031 Free article. Review.

4

Hereditary Hypokalemic Salt-losing Tubular Disorders.

Peters M, Konrad M, Seyberth HW. Peters M, et al. Saudi J Kidney Dis Transpl. 2003 Jul-Sep;14(3):386-97. Saudi J Kidney Dis Transpl. 2003. PMID: 17657111

5

Hereditary hypokalemic salt-losing tubulopathies: Bartter-like syndromes.

Peters M, Jeck N, Seyberth HW, Konrad M. Peters M, et al. Contrib Nephrol. 2001;(136):157-73. doi: 10.1159/000060186. Contrib Nephrol. 2001. PMID: 11688378 Review. No abstract available.

6

Pharmacotyping of hypokalaemic salt-losing tubular disorders.

Reinalter SC, Jeck N, Peters M, Seyberth HW. Reinalter SC, et al. Among authors: peters m. Acta Physiol Scand. 2004 Aug;181(4):513-21. doi: 10.1111/j.1365-201X.2004.01325.x. Acta Physiol Scand. 2004. PMID: 15283765 Review.

7

Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.

Peters M, Jeck N, Reinalter S, Leonhardt A, Tönshoff B, Klaus G Gü, Konrad M, Seyberth HW. Peters M, et al. Am J Med. 2002 Feb 15;112(3):183-90. doi: 10.1016/s0002-9343(01)01086-5. Am J Med. 2002. PMID: 11893344

8

Barttin increases surface expression and changes current properties of ClC-K channels.

Waldegger S, Jeck N, Barth P, Peters M, Vitzthum H, Wolf K, Kurtz A, Konrad M, Seyberth HW. Waldegger S, et al. Among authors: peters m. Pflugers Arch. 2002 Jun;444(3):411-8. doi: 10.1007/s00424-002-0819-8. Epub 2002 Apr 9. Pflugers Arch. 2002. PMID: 12111250

9

Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype.

Jeck N, Konrad M, Peters M, Weber S, Bonzel KE, Seyberth HW. Jeck N, et al. Among authors: peters m. Pediatr Res. 2000 Dec;48(6):754-8. doi: 10.1203/00006450-200012000-00009. Pediatr Res. 2000. PMID: 11102542

10

Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family.

Schlingmann KP, Weber S, Peters M, Niemann Nejsum L, Vitzthum H, Klingel K, Kratz M, Haddad E, Ristoff E, Dinour D, Syrrou M, Nielsen S, Sassen M, Waldegger S, Seyberth HW, Konrad M. Schlingmann KP, et al. Among authors: peters m. Nat Genet. 2002 Jun;31(2):166-70. doi: 10.1038/ng889. Epub 2002 May 28. Nat Genet. 2002. PMID: 12032568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,078 results

Search Page